newsfilter
← Latest News
GlobeNewswire·

Myovant Sciences to Participate at Upcoming Investor Conferences

BASEL, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy, to